Sun Pharmaceutical Industries Ltd posts consolidated PAT of Rs. 2835.62 crores

Sun Pharmaceutical Industries Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 13185.30 crores during the period ended June 30, 2024 as compared to Rs. 12588.84 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 2835.62 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 2654.58 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 11.8 for the period ended June 30, 2024 as compared to Rs. 11.1 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 13185.30 crs	₹12588.84 crs	4.74%
Net Profit	₹2835.62 crs	₹2654.58 crs	6.82%
EPS	₹11.8	₹11.1	6.31%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 13185.30 crores during the period ended June 30, 2024 as compared to Rs.12145.28 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.2835.62 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.2022.54 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.11.8 for the period ended June 30, 2024 as compared to Rs.8.4 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 13185.30 crs	₹12145.28 crs	8.56%
Net Profit	₹2835.62 crs	₹2022.54 crs	40.20%
EPS	₹11.8	₹8.4	40.48%

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1715.95 as compared to the previous close of Rs. 1717.85. The total number of shares traded during the day was 135580 in over 9020 trades.

The stock hit an intraday high of Rs. 1746.00 and intraday low of 1681.95. The net turnover during the day was Rs. 233042085.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries Q1FY25 FY2025 Q1FY2025 ResultUpdate